Compile Data Set for Download or QSAR
Report error Found 435 Enz. Inhib. hit(s) with all data for entry = 9265
TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453880BDBM453880(US10730863, Example 274)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454121BDBM454121(US10730863, Example 591)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453881BDBM453881(US10730863, Example 275)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453878BDBM453878(US10730863, Example 270)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453879BDBM453879(US10730863, Example 271)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453874BDBM453874(US10730863, Example 268)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453877BDBM453877(US10730863, Example 269)
Affinity DataEC50:  1nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453978BDBM453978(US10730863, Example 420)
Affinity DataEC50:  3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453984BDBM453984(US10730863, Example 429)
Affinity DataEC50:  4nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453963BDBM453963(US10730863, Example 403)
Affinity DataEC50:  4nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453782BDBM453782(US10730863, Example 103)
Affinity DataEC50:  4nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453982BDBM453982(US10730863, Example 427)
Affinity DataEC50:  5nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454075BDBM454075(US10730863, Example 545)
Affinity DataEC50:  5nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454045BDBM454045(US10730863, Example 506)
Affinity DataEC50:  6nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453950BDBM453950(US10730863, Example 389)
Affinity DataEC50:  6nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453779BDBM453779(US10730863, Example 100)
Affinity DataEC50:  7nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453902BDBM453902(US10730863, Example 322)
Affinity DataEC50:  7nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454076BDBM454076(US10730863, Example 546)
Affinity DataEC50:  7nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453839BDBM453839(US10730863, Example 192)
Affinity DataEC50:  7.20nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453780BDBM453780(US10730863, Example 101)
Affinity DataEC50:  8nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454059BDBM454059(US10730863, Example 529)
Affinity DataEC50:  9nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453971BDBM453971(US10730863, Example 412)
Affinity DataEC50:  10nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453968BDBM453968(US10730863, Example 408)
Affinity DataEC50:  10nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453996BDBM453996(US10730863, Example 448)
Affinity DataEC50:  10nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453920BDBM453920(US10730863, Example 353)
Affinity DataEC50:  11nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454128BDBM454128(US10730863, Example 598)
Affinity DataEC50:  11nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453768BDBM453768(US10730863, Example 90)
Affinity DataEC50:  11nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454083BDBM454083(US10730863, Example 553)
Affinity DataEC50:  12nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453830BDBM453830(US10730863, Example 183 | US10730863, Example 186)
Affinity DataEC50:  13nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454078BDBM454078(US10730863, Example 548)
Affinity DataEC50:  13nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453917BDBM453917(US10730863, Example 345)
Affinity DataEC50:  14nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454129BDBM454129(US10730863, Example 599)
Affinity DataEC50:  15nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453883BDBM453883(US10730863, Example 283)
Affinity DataEC50:  15nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454058BDBM454058(US10730863, Example 528)
Affinity DataEC50:  16nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453991BDBM453991(US10730863, Example 440 | US10730863, Example 449 ...)
Affinity DataEC50:  16nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454093BDBM454093(US10730863, Example 563)
Affinity DataEC50:  16nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454119BDBM454119(US10730863, Example 589)
Affinity DataEC50:  17nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453906BDBM453906(US10730863, Example 326)
Affinity DataEC50:  17nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453916BDBM453916(US10730863, Example 344)
Affinity DataEC50:  17nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454105BDBM454105(US10730863, Example 575)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453781BDBM453781(US10730863, Example 102)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454133BDBM454133(US10730863, Example 603)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453987BDBM453987(US10730863, Example 434)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454131BDBM454131(US10730863, Example 601)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453921BDBM453921(US10730863, Example 355)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453773BDBM453773(US10730863, Example 94)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 454032BDBM454032(US10730863, Example 493)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453918BDBM453918(US10730863, Example 346)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453934BDBM453934(US10730863, Example 371)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 453998BDBM453998(US10730863, Example 450)
Affinity DataEC50:  18nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

Displayed 1 to 50 (of 435 total ) | Next | Last >>
Jump to: